TCRT 8-K 2026-10-09

Alaunos Therapeutics, Inc. (TCRT) 8-K dated 2026-10-09 — accession 0001193125-26-419154. This URL is the filing, not the TCRT hub.

Alaunos Therapeutics, Inc. (TCRT) is a biotechnology company listed on NASDAQ.

Alaunos Therapeutics, Inc. filed a 8-K on 2026-10-09. Accession 0001193125-26-419154.

Cached items: 3.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TCRT revenue for 2025-12-31 was $5.0K. Net income was -$4.2M. Revenue was down 50.0% from 2024-12-31 to 2025-12-31. TCRT currently screens at market cap $5.6M.

Not investment advice. The TCRT SEC hub lists recent forms. The stock page is the research view.